Sage Journals: Discover world-class research

Abstract

Background

Mental comorbidity is common in multiple sclerosis (MS), but some studies suggest that mental comorbidity may be underrecognized and undertreated.

Objective

Using the North American Research Committee on MS Registry, we assessed the frequency of mental comorbidities in MS and sociodemographic characteristics associated with diagnosis and treatment of depression.

Methods

We queried participants regarding depression, anxiety, bipolar disorder, and schizophrenia. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CESD); a score ≥21 indicated probable major depression.

Results

Mental comorbidity affected 4264 (48%) responders; depression most frequently (4012, 46%). Among participants not reporting mental comorbidity, 751 (16.2%) had CESD scores ≥21 suggesting undiagnosed depression. Lower socioeconomic status was associated with increased odds of depression (Income $15,000–30,000 vs >$100,000 OR 1.34; 1.11–1.62), undiagnosed depression (Income $15,000–30,000 vs >$100,000 OR 1.52; 1.08–2.13), and untreated depression (<high school vs postgraduate degree OR 3.13; 1.65–5.99).

Conclusions

Mental comorbidity remains underdiagnosed and undertreated in MS. Patients of lower socioeconomic status bear a disproportionate share of the burden of depression.

Keywords

comorbidity depression multiple sclerosis psychiatry socioeconomic status

Get full access to this article

View all access options for this article.

References

1 Korostil M Feinstein A . Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007; 13: 67–72.

2 Mohr DC Hart SL Fonareva I Tasch ES . Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler 2006; 12: 204–208.

3 McGuigan C Hutchinson M . Unrecognised symptoms of depression in a community-based population with multiple sclerosis. J Neurol 2006; 253: 219–223.

4 Shabas D Heffner M . Multiple sclerosis management for low-income minorities. Mult Scler 2005; 11: 635–640.

5 Mohr DC Goodkin DE Likosky W Gatto N Baumann KA Rudick RA . Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997; 54: 531–533.

6 Feinstein A . An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002; 59: 674–678.

8 Marrie RA Cutter G Tyry T Campagnolo D Vollmer T . Validation of the NARCOMS registry: diagnosis. Mult Scler 2007; 13: 770–775.

9 Marrie RA Horwitz RI Cutter G Tyry T Campagnolo D Vollmer T . Comorbidity, socioeconomic status, and multiple sclerosis. Mult Scler 2008; 14: 1091–1098.

10.

10 Sangha O Stucki G Liang MH Fossel AH Katz JN . The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003; 49: 156–163.

11.

11 Yancik R Havlik RJ Wesley MN . Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996; 6: 399–412.

12.

12 KJ Rothman S Greenland , (). Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1998.

13.

13 Klein RJ Schoenborn CA . Age adjustment using the 2000 projected U.S. population. Healthy People Statistical Notes. Hyattsville, Maryland: National Center for Health Statistics; 2001. Report No.: 20.

14.

14 Marrie RA Horwitz R Cutter G Tyry T Campagnolo D Vollmer T . Comorbidity, socioeconomic status, and multiple sclerosis. Mult Scler 2008; 14: 1091–1098.

15.

15 Weissman MM Sholomskas D Pottenger M Prusoff BA Locke BZ . Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977; 106: 203–214.

16.

16 Unutzer J Patrick DL Marmon T Simon GE Katon WJ . Depressive symptoms and mortality in a prospective study of 2,558 older adults. Am J Geriatr Psychiatry 2002; 10: 521–530.

17.

17 Pandya R Metz L Patten SB . Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics 2005; 46: 131–134.

18.

18 Hosmer DW Lemeshow S . Applied logistic regression. New York: John Wiley & Sons; 1989.

19.

19 SAS. V9.1 [program]. Cary, NC, USA. Sas Institute Inc; 2002–2003.

20.

20 Goldman Consensus Group . The goldman consensus statement on depression in multiple sclerosis. Mult Scler 2005; 11: 328–337.

21.

21 Rodgers J Bland R . Psychiatric manifestations of multiple sclerosis: a review. Can J Psychiatry 1996; 41: 441–445.

22.

22 Patten SB Svenson LW Metz LM . Psychotic disorders in MS: population-based evidence of an association. Neurology 2005; 65: 1123–1125.

23.

23 Williams RM Turner AP Hatzakis M Bowen JD Rodriquez AA Haselkorn JK . Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology 2005; 64: 75–80.

24.

24 Edwards LJ Constantinescu CS . A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004; 10: 575–581.

25.

25 Fisk J Morehouse SA Brown MG Skedgel C Murray TJ . Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci 1998; 25: 230–235.

26.

26 Joffe RT Lippert GP Gray TA Sawa G Horvath Z . Mood disorder and multiple sclerosis. Arch Neurol 1987; 44: 376–378.

27.

27 Chwastiak L Ehde DM Gibbons LE Sullivan M Bowen JD Kraft GH . Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002; 159: 1862–1868.

28.

28 Tsivgoulis G Triantafyllou N Papageorgiou C . Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients. Acta Neurol Scand 2007; 115: 67–72.

29.

29 Ang DC Choi H Kroenke K Wolfe F . Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1013–1019.

30.

30 Cluss PA Marcus SC Kelleher KJ Thase ME Arvay LA Kupfer DJ . Diagnostic certainty of a voluntary bipolar disorder case registry. J Affect Disord 1999; 52: 93–99.

31.

31 Perala J Suvisaari J Saarni SI . Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64: 19–28.

32.

32 Kessler RC Berglund P Demler O Jin R Koretz D Merikangas KR . The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095–3105.

33.

33 Somers JM Goldner EM Waraich P Hsu L . Prevalence and incidence studies of anxiety disorders: A systematic review of the literature. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2006; 51: 100–113.

34.

34 Woods SW . The economic burden of bipolar disease. Journal of Clinical Psychiatry 2000; 61: 38–41.

35.

35 Kessler RC Birnbaum H Demler O Falloon IRH Gagnon E Guyer M . The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biological Psychiatry 2005; 58: 668–676.

The burden of mental comorbidity in multiple sclerosis: frequent,underdiagnosed,and undertreated

Abstract

Keywords

Get full access to this article

References